| Watsco First Quarter Performance Reflects Stabilizing Markets, Improved Operating Efficiency and Expanded Technology Adoption |
Globe Newswire |
04/28 |
07:30 |
| Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health |
Globe Newswire |
04/28 |
07:30 |
| NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans |
Globe Newswire |
04/28 |
07:30 |
| FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States |
Globe Newswire |
04/28 |
07:24 |
| Exodus Movement Appoints Receiver in United Kingdom to Take Control of Monavate and Baanx |
Globe Newswire |
04/28 |
07:20 |
| Sportradar Appoints Sameer Deen as Chief Operating Officer |
Globe Newswire |
04/28 |
07:07 |
| reAlpha (Nasdaq: AIRE) Reports First-Quarter 2026 Financial Results |
Globe Newswire |
04/28 |
07:05 |
| Hotel101 Global Announces Strong Booking Performance at Hotel101-Madrid |
Globe Newswire |
04/28 |
07:04 |
| DoubleDown Interactive to Report 2026 First Quarter Results on May 12 and Host Conference Call and Webcast |
Globe Newswire |
04/28 |
07:00 |
| Kandi Technologies Reports Full Year 2025 Financial Results |
Globe Newswire |
04/28 |
07:00 |
| Avalo Therapeutics Purchases Optional Milestone Buyout |
Globe Newswire |
04/28 |
07:00 |
| Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026 |
Globe Newswire |
04/28 |
07:00 |
| First Commonwealth Announces First Quarter 2026 Earnings; Increases Quarterly Dividend |
Globe Newswire |
04/28 |
07:00 |
| UNICOM Engineering and Fourier Cooling Collaborate to Deliver Cooling‑Defined Modular AI Data Center Infrastructure |
Globe Newswire |
04/28 |
07:00 |
| Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors |
Globe Newswire |
04/28 |
07:00 |
| Plug To Announce 2026 First Quarter Results on May 11, 2026 |
Globe Newswire |
04/28 |
07:00 |
| Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting |
Globe Newswire |
04/28 |
07:00 |
| Velocity Trade and Kilo Capital Execute First Trades in Abaxx Spot Gold Pool |
Globe Newswire |
04/28 |
07:00 |
| OIO Group Announces Post-Closing Shares Outstanding Following Business Combination |
Globe Newswire |
04/28 |
07:00 |
| Gogo to Report First Quarter 2026 Financial Results on 7 May, 2026 |
Globe Newswire |
04/28 |
07:00 |
| GXO Introduces Europe’s First Autoload System for Grupa Żywiec in Poland |
Globe Newswire |
04/28 |
07:00 |
| LGI Homes, Inc. Reports First Quarter 2026 Results and Raises Full Year Margin Guidance |
Globe Newswire |
04/28 |
07:00 |
| CECO Environmental Reports First Quarter 2026 Results |
Globe Newswire |
04/28 |
07:00 |
| Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline |
Globe Newswire |
04/28 |
07:00 |
| OTC Markets Group Welcomes Viscount Mining Corp to OTCQX |
Globe Newswire |
04/28 |
07:00 |
